So reading the announcement, I am glad that management of I.M.U. have taken the safe option, but it being the slow option at the same time.
So we know first patient dosed yesterday Monday 30th November and I am hoping that the next 2 patient's are recruited before Christmas.
That will leave us with 30 day's result's, occurring in late January 2021, at earliest.
Once the Cohort Review Committee (CRC) is pleased with the out come of the first 3 patient's, then full steam ahead, with the next lot 3 patient's.
While I can see the enthusiasm of share holder's, one must put a lid on it, has I.M.U. have a very long road ahead, with the up's and also the down.
What I am hoping, that the patient's involved, in this trial, do make a full recovery or at least a 50% recovery, as we must remember, these are very sick patient's and some are starring at heaven's door.
Patience is the key with Bio Stock's.
IMHO.
Regards
Rossi70
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-47
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M |
Open | High | Low | Value | Volume |
5.2¢ | 5.2¢ | 5.0¢ | $1.098M | 21.50M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
97 | 7481668 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 1703097 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
89 | 5589588 | 0.050 |
23 | 1947956 | 0.049 |
19 | 1365961 | 0.048 |
8 | 2836679 | 0.047 |
15 | 1604916 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 1703097 | 4 |
0.052 | 3475772 | 11 |
0.053 | 1615148 | 7 |
0.054 | 1375711 | 7 |
0.055 | 1499783 | 10 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online